Hugo R Lara-Martinez: Acute Immune Thrombocytopenia Following First Obinutuzumab Exposure
Hugo R Lara-Martinez, Former Assistant Professor of Medicine-Hematology at MD Anderson Cancer Center, shared a post on LinkedIn about a recent article he and Judy Al-Sayyad co-authored, published in Blood Vessels, Thrombosis and Hemostasis, adding:
“Excited to share our recently published case report, ‘Immune-Mediated Acute Thrombocytopenia Within 30 Minutes of First Obinutuzumab Infusion,’ in Blood Vessels, Thrombosis and Hemostasis.
We describe a rare but potentially serious complication of obinutuzumab, with profound thrombocytopenia developing shortly after the first infusion.
This case highlights the importance of recognizing obinutuzumab-induced acute thrombocytopenia and distinguishing it from other causes of thrombocytopenia in patients receiving anti-CD20 therapy.
A great collaboration with Judy Al-Sayyad and an important clinical reminder that sometimes the timing of an adverse event provides the biggest clue to the diagnosis.”
Title: Immune-mediated acute thrombocytopenia within 30 minutes of first obinutuzumab infusion
Authors: Judy Al-Sayyad, Hugo R Lara-Martinez
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 28, 2026, 14:56Elizabeth Shirley: COVID-19 Vaccines, Spike Protein and Nitric Oxide Bioavailability
-
Oct 28, 2026, 14:39David Ledger: Anticoagulation Advances as Factor XIa Inhibition Reaches a New Milestone
-
Oct 28, 2026, 14:37Advancing Liver Health in Haemophilia Care – EAHAD
-
Oct 28, 2026, 14:34The Changing Landscape of Anticoagulant Therapy – ISTH
-
Oct 28, 2026, 14:17Clusterin Regulates von Willebrand Factor Multimer Stability Through ADAMTS13 Inhibition
-
Oct 28, 2026, 14:14Mina Jarrahi: Platelet-Rich Fibrin for Periodontal Regeneration
-
Oct 28, 2026, 14:06Mohammed Alo: A Stent Treats the Blockage, Not the Underlying Disease
-
Oct 28, 2026, 13:58Vladimir Lemaire: When Blood Clots Affect Elite Athletes
-
Oct 28, 2026, 13:27M. Alejandro Mosso-Pani: Dengue in Florida – Why Platelet Function Matters